Immunology and Neurology Pioneer Dies

Gerald Edelman, who broke new ground in two distinct fields of life science, has passed away at age 84.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, ANDERS ZAKRISSONBiologist Gerald Edelman, who shared the Nobel Prize in physiology or medicine in 1972 for his work on the immune system died this month (May 17). Although the cause of death was unclear, Edelman had prostate cancer and Parkinson’s disease. He was 84.

Edelman discovered that antibodies were made of two peptide chains—one long and one short—instead of one long peptide chain, as was once thought. Starting in the mid-1970s, Edelman shifted his research focus to the brain. He developed a theory that neuronal groups were selected for much like Darwinian selection produces certain phenotypes. He had previously found that antibody selection worked this way. The theory was controversial, but has been supported by subsequent research findings.

“There isn’t going to be any kind of theory of the brain that doesn’t involve elements of his ideas,” Peter Vanderklish, a neuroscientist and colleague of Edelman’s at the Scripps Research Institute in La Jolla, California, told The New York Times. “The brain is never—never has been or ever will be—in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies